RUNX3 and glioma: Therefore, we explored the potential pathway involving miR-19/RUNX3/β-catenin trying to elucidate the related mechanism in glioma, also suggesting that miR-19 may be a possible diagnostic therapeutic approach that deserves further evaluation in GBM.